Down-regulation and desensitization of the β2-AR is observed in many diseases where net SNS firing rate (activity) is chronically elevated and robust/chronic inflammation ensues, including hypertension [146], sepsis [147,148,149], RA [150,151,152], and asthma [153,154,155]. Here, ADRB2 is linked to rheumatoid arthritis.